Positive Angle Kappa | Clinical Trial

Key information

Conditions

Aniridia Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Abnormalities Eye Diseases Eye Diseases, Hereditary Genetic Diseases, Inborn Iris Diseases Uveal Diseases

Age range

1 month–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Minnesota Dept of ophthalmlogy

Minneapolis, Minnesota, 55455, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with aniridia only

Exclusion criteria

poor va
PK,
K-pro

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Official study title

Positive Angle Kappa: a Sign in Aniridia

Important dates

Study start: 2010
Primary completion: 2011
Study completion: 2011
First posted: Jul 19, 2012
Registry last updated: Nov 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed